Track topics on Twitter Track topics that are important to you
Phone: 5411 4315 0840
The scientists of the UEx Molecular Biology of Cancer Research Group have a very clear objective. They want to uncover the physiological mechanisms of the cancer stem cell, the arch-enemy of the pati...
SummaryMarket Segment as follows:By Region AsiaPacific North America Europe South America Middle East AfricaBy Type Sodium Alkyl Aryl Sulfonate OthersBy Application Sodium Alk...
KAIST researchers have identified a reaction mechanism that selectively introduces aryl groups at the desired position of a molecule at room temperature. A team, co-led by Professor Sukbok Chang and M...
SummaryPoly etherketoneketone PEKK is a semicrystalline thermoplastic in the PAEK Poly Aryl Ether Ketone family, with high heat resistance, chemical resistance and the ability to withstand high mechan...
Palladium catalyzed cross-coupling reaction of aryl halides with isoquinoline-1,3(2H,4H)-diones for the synthesis of 4-aryl isoquinoline-1,3(2H,4H)-diones was developed. The reaction conditions exhibi...
Arylfullerenyl cations (ArC), which were generated by heating arylfullerenyl dimers (ArC-CAr) to generate arylfullerenyl radicals (ArC) followed by oxidation using Cu(II) salts (Cu(BF)(aq)...
The Pd-catalyzed regioselective C-H activation/arylation, /iodination, and/acetoxylation reactions of 4-arylpyrimidines using aryl iodides, N-iodosuccinimide, and (diacetoxyiodo)benzene respectively a...
Although aryl(trialkyl)silanes are apparently ideal organometalic reagents for the cross-coupling reaction due to robustness, low toxicity, solubility, and easy accessibility, they are generally an in...
A synthetic method has been developed for the synthesis of unsymmetrical ferrocene aryl chalcogenides by C-H activation of ferroceneamide using 8-aminoquinoline as a directing group, aryl dichalcogeni...
The prognosis for patients with metastatic or locally advanced hepatocellular carcinoma (HCC) is poor. The role of conventional systemic chemotherapy has been very limited because most ch...
This study will investigate the effects and side effects of BAY 43-9006 in patients with advanced, recurrent, or refractory non-small cell lung cancer (NSCLC). BAY 43-9006 is one of a new ...
ARYLS.A.started its business as a pharmachemical company in 1998.The manufacturing site and the administration offices are located in Bureros Aires,Aregentina.The Company employs more than 100 people
We have published hundreds of Aryl S.A news stories on BioPortfolio along with dozens of Aryl S.A Clinical Trials and PubMed Articles about Aryl S.A for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aryl S.A Companies in our database. You can also find out about relevant Aryl S.A Drugs and Medications on this site too.